Dr Uzochukwu Egere

Post-doctoral research associate (Health Systems)

Dr Uzochukwu Egere is a medical graduate from the University of Jos, Nigeria and trained as a Paediatrician at the University College Hospital Ibadan, Nigeria. He holds a masters’ degree in Public Health from the University of Otago, New Zealand and a PhD from Ludwig-Maximillian University, Munich, Germany. Uzoh’s PhD was on the opportunities and challenges of contact tracing and Isoniazid preventive therapy as a control strategy for childhood TB in The Gambia.

Uzoh worked briefly as a consultant paediatrician at St Nicholas Hospital, a leading private hospital in Lagos before joining the Medical Research Council Unit, The Gambia in 2006 as a research Clinician. At the MRC, he worked on a series of pneumococcal carriage studies and led a 3-year community randomised controlled trial of the 7-valent pneumococcal conjugate vaccine in rural Gambian villages which assessed impact of community vaccination on pneumococcal carriage in children and adults.

In 2011, Uzoh joined the newly established Childhood TB Program at the MRC Gambia as the lead Clinician and Coordinator. In this role, he conducted household contact tracing, ran a dedicated childhood TB clinic and a home-delivered isoniazid preventive therapy project. He provided guidance to the National TB Program of The Gambia on management of Childhood TB. Uzoh was also principal investigator of a capacity building project funded by the Special Programme for Research and Training in Tropical Diseases (TDR). This project involved training of frontline on management of TB in children and assessed the impact of the training project on health workers’ knowledge and notification of childhood TB in The Gambia.

In 2016, He began to lead the first ever implementation of contact tracing and isoniazid preventive therapy within the routine health system of The Gambia. He played a key role in developing childhood TB control policies for both governments of The Gambia and Liberia. Until joining the LSTM in June 2018, Uzoh was co-principal investigator and coordinator of the “Reach4Kids Africa”, a childhood TB collaborative research partnership of four sub Saharan African countries – The Gambia, Mali, Nigeria and Tanzania.

Research

Uzoh currently works as a post doc researcher on the health systems/social sciences portfolio of the International Multidisciplinary Programme to Address Lung Health and Tuberculosis in Africa (IMPALA) project which focuses on developing, implementing and evaluating equitable approaches to management of chronic lung diseases within the routine health systems in Sudan and Tanzania.

Other research interests include

-       Implementation research on community health systems and role of community health workers in recognition and referral of chronic lung diseases at the community level

-       Approaches to improving management of childhood TB in resource-limited settings with focus on contact tracing and increasing programmatic implementation and uptake of isoniazid preventive therapy

-       Chronic lung disease in children including post TB lung disease and asthma

Teaching

Dr Egere contributes Childhood TB, Lung health and HIV teaching to the Masters in Tropical Paediatrics, Masters in Tropical and Infectious Diseases, and Diploma in Tropical Nursing programmes of the LSTM.

Dr Egere is -

Fellow, West African College of Physicians (Paediatrics)
Registered Practitioner, Medical and Dental Council of Nigeria, Medical and Dental Council of The Gambia
Member, European Society of Paediatric Infectious Diseases
Member, International Union of Tuberculosis and Lung Diseases

Member, Global Health Policy and Systems Community

 

 

Selected publications

  • Selected publications

    Egere U, Togun T, Sillah A K, Mendy F et al (2016): Identifying children with tuberculosis among household contacts in The Gambia. The International Journal of Tuberculosis and Lung Disease. Volume 21, Number 1, 1 January 2017, pp. 46-52(7)
    Egere U, Sillah A K, Togun T, Cole F (2016): Isoniazid preventive treatment among child contacts of adults with smear positive tuberculosis in The Gambia. Public Health Action, Volume 6, Number 4, 21 December 2016, pp. 226-231(6)
    Toyin T, Egere U and Kampmann B. “Childhood tuberculosis: new tools and remaining challenges.” Recent Advances in Paediatrics (2014), Vol 26; Chapter 1, pp 1-10

    Togun TO, Egere U, Gomez MP, Sillah AK, Daramy M, Tientcheu LD, et al. No added value of interferon-γ release to a prediction model for childhood tuberculosis. European Respiratory Journal. 2016;47(1):223-32.
    Egere U, Townend J, Roca A, Akinsanya A et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural gambia: a randomised controlled trial. PLoS ONE 01/2012; 7(11): e49143
    Togun T, Egere U, Sillah A, Ayorinde A, Mendy F, Tientcheu L, et al. Contribution of Xpert® MTB/RIF to the diagnosis of pulmonary tuberculosis among TB-exposed children in The Gambia. The International Journal of Tuberculosis and Lung Disease. 2015;19(9):1091-7.